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Purpose: To evaluate the occurrence of plasmid-mediated quinolone resistance (PMQR) genes and the 
prevalence of extended spectrum β-lactamase (ESBL) types in Escherichia coli clinical isolates.  
Methods: Sixty-one ESBL-producing urinary E. coli isolates were studied. An antibiotic susceptibility test was 
performed using the disc diffusion method. ESBL production was determined using a double-disc synergy test 
for all isolates; E-test and Vitek 2 were used for plasmid-mediated quinolone resistance (PMQR)-positive 
isolates and their transconjugants. The presence of PMQR and β-lactamase genes was determined by 
polymerase chain reaction (PCR).  
Results: The strains displayed high rates of resistance to norfloxacin (80 %). The most frequent PMQR gene 
was aac(6’)-Ib-cr (45.9 %).  In all, one qnrA1 (1.6 %), one qnrS1 (1.6 %), and two qepA1-positive isolates (5.7 
%) were identified. The genes, qnrS1+aac(6’)-Ib-cr and qepA1, were co-expressed with blaCTX-M-15 gene, while 
qnrA1 occurred with blaTEM-1, blaSHV, and blaVEB-1 genes. The most frequent β-lactamase type was 
cefotaximase (CTX-M), which generally hydrolyzes cefotaxime (92 %) more than it does ceftazidime; followed 
by temoneira (TEM, 39 %); sulfhydryl variable (SHV, 5 %), and Vietnamese extended-spectrum beta–
lactamase (VEB, 1.6 %). 
Conclusion: A high prevalence of aac(6’)-Ib-cr and CTX-M type β-lactamase was detected in ESBL-
producing E. coli strains. This study also identified the co-expression of qnrA1 and blaVEB-1 genes and of 
qnrS1+aac(6’)-Ib-cr in E. coli isolates. The co-existence of PMQR genes with ESBLs may lead to a serious 
public health problem. 
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INTRODUCTION 
 
Although bacterial resistance to quinolones is 
usually due to chromosomally encoded 
mechanisms, it can also originate from 
plasmid-mediated genes. After the 
identification of qnr determinants, which 
protect target enzymes against quinolone 
inhibition, two other mechanisms have now 
been described: the qepA gene encodes an 
efflux pump, which confers reduced 
susceptibility on hydrophobic 
fluoroquinolones such as norfloxacin and 
ciprofloxacin; and the aac(6’)-Ib-cr gene, 
which encodes modified aminoglycoside-
acetylating enzymes and can inactivate both 
aminoglycosides and fluoroquinolones [1-3].  
 
Over the last decade, plasmid-mediated 
quinolone resistance (PMQR), particularly 
among the various species of 
Enterobacteriacae, has been increasingly 
reported from many regions of the world.  
Plasmids carrying genes may contribute to 
the development of higher levels of 
fluoroquinolone resistance and may pose a 
threat by allowing the rapid spread of 
resistance among organisms. Although these 
PMQR genes have been associated with low 
levels of quinolone resistance, it could cause 
high-level quinolone resistance by facilitating 
the selection of chromosomal mutations. 
Several studies have demonstrated that most 
qnr-positive enterobacterial isolates are 
associated with extended spectrum β-
lactamases (ESBLs), including TEM, SHV, 
VEB, and CTX-M types, which are generally 
located on plasmids that are highly 
transferable and may harbor resistance 
genes to several different groups of 
antibiotics [4]. Today, many antibiotics, such 
as β-lactams and fluoroquinolones, which are 
widely prescribed by clinicians for the 
treatment of urinary tract E. coli infection, are 
in limited use. 
 
The production of ESBLs and PMQR proteins 
are a cause for concern. The ciprofloxacin 
resistance and ESBL rates are high in E. coli 
isolates from Turkey, being 40 - 42% and 
28.7 - 32.1 %, respectively [5,6]. However, 
significantly lower ciprofloxacin resistance 
and ESBL rates among E. coli in North 
America, Latin America, and Europe were 
observed - 4.5 - 1.9 %, 7.1 - 9.0 %, and 5.0 - 
5.4 %, respectively [7]. Data on the 
prevalence of ESBL, especially CTX-M and 
VEB types, are limited in Turkey. Although 
the prevalence of PMQR genes, qnrA, qnrB, 
qnrS, aac(6’)-Ib-cr, and recently qepA and 
associated ESBLs have been reported, the 
prevalence of qnrC and qnrD  is unknown [8-
11]. 
 
The aim of this study was to determine the 
prevalence of PMQR genes and ESBL types 
in clinical urinary isolates of E. coli collected 
from two large teaching hospitals located in 







A total of 61 consecutive non-repetitive 
ESBL-producing E. coli strains, from the 
years 2008 and 2009, were collected from 
the Microbiology Laboratories of two teaching 
hospitals in Istanbul, Turkey. One of the 
hospitals, Istanbul Medical Faculty (IMF, 
1.750 beds), is located in the European part 
of Istanbul, while the other, Gulhane Military 
Medical Academy Haydarpasa Training 
Hospital (GMMA, 1000 beds), is in the Asian 
section of Istanbul. Isolates from Istanbul 
Medical Faculty (n = 26) and from Gulhane 
Military Medical Academy Haydarpasa 
Training Hospital (n = 35) were included. The 
isolates were collected from urine specimens 
and isolated and identified with the aid of 
Chromogenic medium and Vitek 2 System 
(bioMérieux, France). 
 
Antimicrobial susceptibility and synergy 
testing 
 
Individual strains were tested based on the 
recommendations of the Clinical and 
Laboratory Standards Institute (CLSI), using 
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the Kirby–Bauer disc diffusion method for 
susceptibility [12]. The double disc synergy 
test with cefotaxime and ceftazidime was 
used for screening ESBL production.  
 
The following antibiotic discs (Oxoid, 
Hampshire, UK) were purchased and used, 
as instructed by the manufacturer: 
amoxicillin-clavulanic acid (20/10 µg), 
imipenem (10 µg), gentamicin (10 µg), 
norfloxacin (10 µg), co-trimoxazole 
(1.25/23.75 µg), nitrofurantoin (300 µg), and 
fosfomycin (200 µg). E. coli 25922 was used 
as control strain. For PMQR-positive isolates 
and their transconjugants, the minimal 
inhibitory concentration (MIC) of ampicillin, 
amoxicillin-clavulanic acid, piperacillin-
clavulanic acid, cefazolin, cefuroxime, 
cefoxitin, ceftazidime, ceftriaxone, cefepime, 
ertapenem, imipenem, meropenem, 
amikacin, gentamicin, levofloxacin, 
tigecycline, and co-trimoxazole were 
determined by Vitek 2 System. The MICs of 
ciprofloxacin were determined by E-test 
method (AB, Biodisk, Solna, Sweden).  
 
Enterobacterial repetitive consensus PCR 
(ERIC-PCR) 
 
The Enterobacterial Repetitive Intergenic 
Concensus (ERIC)-PCR with ERIC1 and 
ERIC2 primers was used to analyze the 
epidemiological relationship between PMQR-
positive E. coli isolates. Cycling conditions 
were as follows: 5 min at 94 °C; 40 cycles of 
1 min at 94 °C, 1 min at 36 °C, 2 min at 72 
°C; and final extension of 10 min at 72 °C. 
The PCR products were separated by 
electrophoresis in 1.5 % agarose gel and 
visualized on a UV transilluminator, and 
fingerprints were compared [13]. 
 
Transferability of PMQR genes and 
plasmid analysis 
 
Conjugation experiments with an azide-
resistant E. coli J53 (AzR) as the recipient 
were performed in liquid culture media, as 
described previously [14]. Transconjugants 
were selected on trypticase soy agar plates 
containing sodium azide (100 µg/ml) for 
counter selection and amoxicillin (100 µg/ml), 
cefotaxime (8 µg/ml), ceftazidime (8 µg/ml), 
nalidixic acid (16 µg/ml). The High Pure 
Plasmid Isolation Plasmid DNA Kit (Roche, 
Mannheim, Germany) was used for the 
extraction of plasmid DNA. E. coli V517 cells 
harboring plasmids of 54.4, 7.1, 5.6, 5.2, 3.0, 
2.7, and 2.1 kb were used as the size marker 
for the plasmids. The presence of transferred 
PMQR genes and related ESBLs were 
confirmed by PCR. 
 
Characterization of ESBL and PMQR 
genes and sequencing 
 
DNA extraction was performed, as described 
previously. Briefly, bacterial colonies were 
suspended in 2 ml centrifuge tubes and then 
centrifuged at 12,000 g. The pellets were 
washed in 750 µl TE buffer (10 mM Tris HCl, 
pH 8.0, 1 mM EDTA) and then boiled for 10 
min in 500 µl TE buffer and centrifuged. The 
supernatants were stored at -20 °C prior to 
subsequent DNA amplification [9]. 
 
The blaTEM, blaSHV, blaCTX-M, and blaVEB genes 
were investigated by PCR, as previously 
described [15,16]. A multiplex PCR was 
performed to detect qnrA, qnrB, and qnrS, as 
previously described by Cattoir et al [17]. 
PCR amplification of qnrC, qnrD, qepA, and 
aac (6’)-Ib was carried out with specific 
primers and conditions [2,3,18]. The DNA for 
control for each specific gene region was 
included with each group of tested strains. 
After PCR amplifications, the products of 
aac(6’)-Ib positives were further analysed by 
digestion with BtsCI for detection of the –cr 
variant (New England Biolabs, Ipswich, MA, 
USA). 
 
The amplification products of PMQR and 
related β-lactamases were sequenced with 
an Applied Biosystems sequencer (ABI 
PRISM 310 Genetic Analyzer; Applied 
Biosystems, Foster City, CA, USA). The 
nucleotide and amino acid sequences were 
analyzed and compared by BLAST search 
(www.ncbi.nlm.nih.gov).  
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Statistical analysis  
 
Statistical analysis was performed using 
SPSS for Windows, version 11.5 (SPSS, Inc, 
Chicago, IL, USA). Rates of resistance were 
compared using the Chi-square test. A p-





Antibiotic susceptibilities and the 
prevalence of PMQR determinants/β-
lactamase genes 
 
Table 1 shows the prevalence and 
susceptibility data. The strains displayed 
highest resistance to norfloxacin (80 %). The 
most active antibiotics were imipenem (100 
%), fosfomycin (100 %) and nitrofurantoin 
(93.4 %). The rate of resistance to 
amoxicillin-clavulanic acid for the isolates of 
IMF was higher than that of the isolates of 
GMMA (p = 0.022); the opposite was found 
for the resistance to norfloxacin (p = 0.001). 
Co-resistance was identified in 96 % of the 
strains. The highest co-resistance was 
determined for norfloxacin and the most 
common two co-resistance phenotypes were 
amoxicillin-clavulanic acid/norfloxacin/co-
trimoxazole (24.5 %) and amoxicillin-
clavulanic acid/gentamicin/norfloxacin/co-
trimoxazole (15 %). 
 
The prevalence of PMQR genes for aac(6’)-
Ib-cr, qepA, qnrA, and qnrS were 45.9, 5.7, 
1.6, and 1.6%, respectively. qnrA1 and 
qepA1 were detected alone in strains, but 
qnrS1 was co-expressed with aac(6’)-Ib-cr. 
All PMQR-positive isolates were resistant to 
norfloxacin, except the qnrA1- positive strain. 
In addition, norfloxacin resistance in aac(6’)-
Ib-cr-positive isolates (all were resistant) was 
significantly higher than in the aac(6’)-Ib-cr-
negative ones (p = 0.001). No isolates 
carrying the qnrB, qnrC, or qnrD genes were 
detected in this study (Table 1). The most 
prevalent ESBL type was CTX-M (92 %) 
(mostly CTX-M group 1 (66 %)), followed by 
TEM and SHV. Only one isolate harbored the 
VEB-1 type β-lactamase. Ciprofloxacin-
resistant E. coli 4 and E. coli 6 were isolated 
from patients with nephrolithiasis, who were 
operated in the same division of GMMA 
during the same period, and these were 
qepA1-positive. E. coli 4 was isolated 36 
days after the operation and the patient was 
treated with fosfomycin. E. coli 6 was isolated 
from a patient who was admitted with high 
fever 11 days after the operation and treated 
with a imipenem-gentamicin combination. 
Ciprofloxacin-resistant E. coli34 (from a 
kidney transplant patient treated with 
piperacillin-tazobactam) and ciprofloxacin-
susceptible E. coli 210 (from a patient who 
was born with premature rupture of 
membranes treated with an ampicillin-
gentamicin combination) were isolated in 
different divisions of ITF. E. coli 24 harbored 
both qnrS1 and aac(6’)-Ib-cr, while qnrA1 
was detected in E. coli 210. 
 
RAPD-PCR typing  
 
E. coli 4 and E. coli 6 have similar antibiotic 
patterns; i.e., they are resistant to amoxicillin-
clavulanic acid, cefriaxone, amikacin, 
gentamicin, norfloxacin, levofloxacin, and co-
trimoxazole. RAPD-PCR typing was carried 
out on the four PMQR-positive isolates. The 
results showed that the qepA1-positive 
isolates were clonally related (data not 
shown). 
 
Characteristics of PMQR-positive isolates, 
transconjugants, and plasmid analysis 
 
PCR assays were used to detect β-
lactamase, and identified the blaCTX-M-15 gene 
in E. coli 4, E. coli 6, and E. coli 34, while 
blaTEM-1, blaSHV, and blaVEB-1 genes were 
detected in E. coli 210. Despite three 
separate attempts, conjugative assays failed 
with the E. coli 4 and E. coli 6 isolates. 
However, plasmid analysis demonstrated that 
both strains harbored multiple plasmids 
changing 1-7 kb (Figure 1).  
 
The pattern of susceptibility to the β-lactams 
of the transconjugants corresponded to the  
 
Nazik et al  
Trop J Pharm Res, June 2011;10 (3): 329 






















































45.9 39 5 92 66 1.6 69 0 43 80 70.5 6.6 0 
GMMA 
 (n=35) 0 0 0 0 0 3.3 51.4 26 0 91 69 0 57 0 43 94 69 3 0 
IMF  
(n=26) 3.8 0 3.8 0 0 0 
 
38.5 58 11.5 92 61.5 3.8 85 0 42 61.5 73 11.5 0 
P 0.242 - 0.242 
 
- - 0.215 
 
0.315 0.011 0.039 0.901 0.568 0.242 0.022 - 0.966 0.001 0.703 0.176 - 
 
IMF: Istanbul Medical Faculty, GMMA: Gulhane Military Medical Academy Haydarpasa Training Hospital, R: Resistance, 
AMC: Amoxicillin-clavulanic acid, IPM: Imipenem, GN: Gentamicin, NOR: Norfloxacin, SXT: CO-trimoxazole, NIT: 
Nitrofurantoin, FOS: Fosfomycin. 
 
expression of clavulanic acid-inhibited 
ESBLs. Transfer of the qnrS1+aac(6’)-Ib-cr 
and blaCTX-M-15 of E. coli 34 and qnrA1, blaTEM-
1, blaSHV, and blaVEB-1 gene of E. coli 210 to 
the azide-resistant E. coli J53 occurred 
during the conjugation experiments. 
Tranconjugants of E. coli 34 were resistant to 
amoxicillin-clavulanic acid, cefriaxone, 
amikacin, gentamicin, levofloxacin, and co-
trimoxazole. Transconjugants of E. coli 210 
were resistant to cefriaxone, gentamicin, and 
co-trimoxazole.  
 
The MICs of ciprofloxacin and other 
antibiotics for E. coli 34 and E. coli 210 
parenteral isolates and their transconjugants 
are presented in Table 2. The MICs for 
ciprofloxacin were increased 63 and 8 times 





It is more difficult to treat ESBL-producing E. 
coli because most β-lactams are no longer 
therapeutic options. In particular, CTX-M type 
enzymes have emerged worldwide and have 
rapidly increased in E. coli isolated from both 
community and nosocomial settings [19]. The 
associated co-resistance of ESBL producers 
to different groups of antimicrobials, such as 
quinolones, sulfonamides, and aminogly-







Fig 1: Plasmid DNAs from E. coli 4 and E. coli 6. 
Line M, E. coli V 517 (used as standard for 
plasmid size) 
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Table 2: MICs of β-lactam and non-β-lactam antibiotics* 
 
 
*MICs of E.coli 34, E.coli 210 and their transconjugants, E.coli 4 (p4), E.coli 6 (p6) and E.coli J53 were indicated. AMP: 
Ampicillin, AMC: Amoxicillin–clavulanic acid, TZP: Piperacillin-tazobactam; CZ: Cefazolin, CXM: Cefuroxime, FOX: 
Cefoxitin, CAZ: Ceftazidime, CRO: Ceftriaxone, FEP: Cefepime, ETP: Ertapenem,  IPM: Imipenem, MEM: Meropenem; 
AK: Amikacin; GN: Gentamicin;; CIP: Ciprofloxacin, LEV: Levofloxacin,  TG: Tigecycline,  SXT: CO-trimoxazole 
 
Limited data have been reported on the 
epidemiology of E. coli that produce CTX-M 
type enzymes in Turkey. Two recent reports 
from Turkey have shown that the CTX-M 
enzyme is common among ESBL positive 
isolates (86.8 %) at our hospital (IMF) in 
Istanbul [20] and from patients with urinary 
tract infections (76.5%) [21]. The latter finding 
of the predominance of CTX-M type enzymes 
according to TEM and SHV types is reflected 
in our study, as well. These reports suggest 
that CTX-M type enzymes are more prevalent 
than other ESBLs in Turkey. Consistently, a 
high prevalence of CTX-M type enzymes has 
been reported in several studies from other 
countries. In addition, the present study 
demonstrates that the prevalence of VEB 
type β-lactamase is low (1.6 %). 
 
Over the past 10 years, PMQR has emerged 
as an important issue. Different rates of 
PMQR have been reported depending on the 
country of origin of the isolates [22]. E. coli 
carrying qnrA, qnrB, qnrS, and aac(6’)-Ib-cr 












































AMP ≥32 ≥32 ≥32 ≥32 ≥32 ≥32 ≤2 
AMC 16 16 ≥32 ≥32 16 4 4 
TZP 8 8 ≥128 ≥128 ≤4 ≤4 ≤4 
CZ ≥64 ≥64 ≥64 ≥64 ≥64 8 ≤4 
CXM ≥64 ≥64 ≥64 ≥64 ≥64 16 4 
FOX 32 32 8 ≤4 ≤4 ≤4 4 
CAZ 16 ≥64 ≥64 16 ≥64 4 ≤1 
CRO ≥64 ≥64 ≥64 ≥64 ≥64 ≤1 ≤1 
FEP 8 32 ≥64 ≥64 ≤1 ≤1 ≤1 
ETP ≤0,5 ≤0,5 ≤0,5 ≤0,5 ≤0,5 ≤0,5 ≤0,5 
IMP ≤1 ≤1 ≤1 ≤0,5 ≤1 ≤1 ≤1 
MEM ≤0,25 ≤0,25 ≤0,25 ≤0,25 ≤0,25 ≤0,25 ≤0,25 
AK 4 4 16 ≤0,25 16 ≤2 ≤2 
GN ≥16 ≥16 ≥16 4 ≥16 ≥16 ≤1 
CIP >32 >32 >32 0.38 0.094 0.047 0.006 
LEV ≥8 ≥8 ≥8 1 0,5 0,5 ≤0,12 
TG ≤0,5 ≤0,5 ≤0,5 ≤0,5 ≤0,5 ≤0,5 ≤0,5 
SXT ≥320 ≥320 ≥320 ≥320 ≥320 ≥320 ≤20 
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genes have been previously reported in 
Turkey [8-10,23]. In the present study, the 
most prevalent PMQR determinant was 
aac(6’)-Ib-cr (45.9%). A low prevalence was 
detected for the other PMQR genes (0 - 5.7 
%). Many studies have demonstrated an 
association between TEM-SHV-CTX-M type 
β-lactamases and PMQR in 
Enterobacteriaceae [4].  
 
In Turkey, as in previous reports, PMQR 
genes were mostly associated with TEM, 
SHV, and CTX-M type β-lactamases, such as 
the qnrS1+aac(6’)-Ib-cr -blaCTX-M-15 
positive E. coli 34 strain in this study. The 
association of qnrA with VEB-1 type β-
lactamases was first investigated in a single 
Enterobacter cloacae isolate from France and 
in 11 out of 23 blaVEB-1 positive 
enterobacterial isolates from Thailand, by 
Poirel et al [16]. In addition, a qnrA-positive-
Citrobacter freundii isolate that produces 
blaVEB-1 and blaOXA-48 has been reported in 
Turkey [8]. Here, in addition to the TEM and 
SHV type, a VEB type β-lactamase was 
detected, but distinct from that of a qnrA-
positive E. coli isolate from the same hospital. 
This finding showed that VEB-1 type β-
lactamase persists in microorganisms in 
Turkey. The present study also demonstrated 
the co-expression of the PMQR genes, 
similar to previous reports from France, UK, 
China, and Turkey [11,24-26].  
 
The strain, qepA, was first identified in 2007 
in two E. coli clinical isolates from Japan and 
Belgium [27], while a new variant (qepA2) 
has already been detected in France [28]. 
However, recently, a qepA producing E. coli 
strain possessing qnrB2 and aac(6’)-Ib-cr 
gene has been reported in Turkey [11]. In the 
present study, in addition to qnrA1, qnrS1 
and aac(6’)-Ib-cr, qepA1-positive E. coli 
isolates that produce CTX-M-15 type β-
lactamase were indentified. No qepA was 
found in the isolates screened in ITF, in 
contrast to other hospitals located in the 
Asian part of Istanbul. Although these PMQR 
mechanisms are rare, the association of 
qepA1 with multi-drug resistant CTX-M-15 
producing E. coli can be a cause for concern. 
There may be a rapid spread of E. coli, 
especially in hospital settings where various 
antimicrobials are largely used and thus may 





This study documents the high prevalence 
aac(6’)-Ib-cr and CTX-M type enzymes in 
Turkey. In addition to aac(6’)-Ib-cr and CTX-
M type enzymes, the qepA1 and VEB-1 type 
enzymes are alarming for Turkey. Our study 
confirms that CTX-M producing E. coli 
isolates from urine specimens are highly 
resistant/co-resistant to norfloxacin, co-
trimoxazole, amoxicillin-clavulanic acid, and 
gentamicin. Empiric therapy with these 
antibiotics may not be adequately effective. 
However, fosfomycin and nitrofurantoin 
resistance rates seem low and they may be 
alternatives for therapy. The emergence of 
the combination of PMQR and ESBL 
compromise the usage of valuable antibiotics 
worldwide. Antibiotic resistance is a public 
health problem, which requires continuous 
surveillance, monitoring, and revision of the 
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